Chi Fong
Stock Analyst at B of A Securities
(0.33)
# 3,143
Out of 4,424 analysts
6
Total ratings
50%
Success rate
-29.91%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Maintains: Neutral | $11 → $12 | $11.13 | +7.82% | 2 | Jan 2, 2024 | |
| CCCC C4 Therapeutics | Maintains: Neutral | $5 → $2 | $6.16 | -67.53% | 3 | Oct 9, 2023 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $10 | $5.56 | +79.86% | 1 | Mar 28, 2023 |
Roivant Sciences
Jan 2, 2024
Maintains: Neutral
Price Target: $11 → $12
Current: $11.13
Upside: +7.82%
C4 Therapeutics
Oct 9, 2023
Maintains: Neutral
Price Target: $5 → $2
Current: $6.16
Upside: -67.53%
Foghorn Therapeutics
Mar 28, 2023
Initiates: Buy
Price Target: $10
Current: $5.56
Upside: +79.86%